Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Eurofins Scientific SE

Derivative Disposition Under Employee Benefit Plan

Derivative Acquisition Under Employee Benefit Plan

Insider	Title	Transaction Type	Shares Traded	% of Shares Traded	% Chg. in Shares	End of Filing Shares	Price	Transaction Value	Filing Date	Transaction Date
Francois Vigneau	Senior Vice President of Food & Feed Testing - Western Europe Show All	Derivative Disposition Under Employee Benefit Plan (Sale)	-200	—	—	—	—	—	15 Jan 2024	12 Jan 2024 - 12 Jan 2024
Fereshteh Pouchantchi	Independent Non-Executive Director Show All	Derivative Acquisition Under Employee Benefit Plan (Buy)	1.1K	—	—	—	—	—	05 Dec 2023	27 Nov 2023 - 27 Nov 2023
Fereshteh Pouchantchi	Independent Non-Executive Director Show All	Derivative Acquisition Under Employee Benefit Plan (Buy)	500	—	—	—	—	—	23 Nov 2023	23 Nov 2023 - 23 Nov 2023
Fereshteh Pouchantchi	Independent Non-Executive Director Show All	Derivative Acquisition Under Employee Benefit Plan (Buy)	600	—	—	—	—	—	23 Nov 2023	23 Nov 2023 - 23 Nov 2023
Timothy S. Oostdyk	Chief Operating Officer and Executive Vice President, President, Executive VP of BioPharma, Genomics & Agrosciences Services North America Show All	Derivative Acquisition Under Employee Benefit Plan (Buy)	16.8K	—	—	—	—	—	17 Nov 2023	31 Oct 2023 - 31 Oct 2023
Christian Wurst
Brian Williams
Natalia Alexanrovna Shuman
Beth Dipaolo
Sean Murray
Laurent Lebras
Gabriel Julia
Joachim Reichelt
Yvoine Remy
Francois Vigneau
Ramon Armas
Francois Vigneau
Timothy S. Oostdyk
Christian Wurst
Brian Williams
Natalia Alexanrovna Shuman
Beth Dipaolo
Sean Murray
Laurent Lebras
Gabriel Julia
Joachim Reichelt
Yvoine Remy
Francois Vigneau
Ramon Armas
Sandra Hoeylaerts